This clinical trial is looking at a drug called BT1718 in adult patients with advanced solid
tumours. The main aim of the study is to find the maximum dose of BT1718 that can be given
safely to patients; learn more about the potential side effects of BT1718 and how they can be
treated and also what happens to BT1718 inside the body.